Advertisement Galderma R&D Selects Agilent's Electronic Lab Notebook - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Galderma R&D Selects Agilent’s Electronic Lab Notebook

Agilent Technologies (Agilent) and Galderma R&D have announced that the latter has adopted the Agilent Electronic Lab Notebook (ELN), to automate scientific data management at its main R&D center devoted to dermatological research and development.

The company claims that ELN provides numerous benefits beyond eliminating paper lab notebooks. The open architecture is designed to simplify and accelerate the R&D process by streamlining data capture, speeding data search and retrieval, and eliminating redundant data entry. The system facilitates cross-team collaboration and integrates with existing processes and procedures. It contains safeguards for intellectual property and maintains record traceability.

Catherine Parigot, project leader of information management department at Galderma R&D, said: “We involved our end users in demonstration sessions based on our workflow for chemistry. After comparison with the leading solutions on the market, the user choice of Agilent ELN was unanimous. This was based largely on the ergonomics of the interface and the intuitive navigation through the different functions. Agilent was also able to demonstrate integration with existing information systems, such as our SDMS and our molecular registration system.”

Debra Toburen, senior product manager of informatics at Agilent, said: “Electronic lab notebook systems is a very competitive category and we are extremely pleased that the Galderma team recognized the efficiencies, ease-of-use and high-level of support of the Agilent ELN. This is just the latest example of the rapid growth of the Agilent ELN product line.”